ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch μ region

被引:65
作者
Pan-Hammarström, Q
Dai, SJ
Zhao, YF
van Dijk-Härd, IF
Gatti, RA
Borresen-Dale, AL
Hammarström, L
机构
[1] Huddinge Hosp, IMP1, Karolinska Inst, Div Clin Immunol, SE-14186 Stockholm, Sweden
[2] Karolinska Inst, NOVUM, Ctr Biotechnol, Huddinge, Sweden
[3] Karolinska Inst, NOVUM, Ctr Oral Biol, Huddinge, Sweden
[4] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
[5] Univ Calif Los Angeles, Dept Pathol, Sch Med, Los Angeles, CA 90095 USA
[6] Norwegian Radium Hosp, Inst Canc Res, Dept Genet, Oslo, Norway
关键词
D O I
10.4049/jimmunol.170.7.3707
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class switch recombination (CSR) and somatic hypermutation (SHM) are mechanistically related processes that share common key factors such as activation-induced cytidine deaminase. We have previously shown a role for ATM (mutated in ataxia-telangiectasia) in CSR. In this paper we show that the frequency, distribution, and nature of base pair substitutions in the Ig variable (V) heavy chain genes in ataxia-telangiectasia patients are largely similar to those in normal donors, suggesting a normal SHM process. Characterization of the third complementarity-determining region in B cells from ataxia-telangiectasia patients also shows a normal V(D)J recombination process. SHM-like mutations could be identified in the switch (S) mu region (up to several hundred base pairs upstream of the Smu-Salpha breakpoints) in normal in vivo switched human B cells. In the absence of ATM, mutations can still be found in this region, but at less than half the frequency of that-in normal donors. The latter mutations are mainly due to transitions (86% compared with 58% in controls) and are biased to A or T nucleotides. An ATM-dependent mechanism, different from that generating SHM in V genes, is therefore likely to be involved in introducing SHM-like mutations in the S region. ATM may thus be one of the factors that is not shared by the CSR and SHM processes.
引用
收藏
页码:3707 / 3716
页数:10
相关论文
共 52 条
[1]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[2]   Atm-deficient mice: A paradigm of ataxia telangiectasia [J].
Barlow, C ;
Hirotsune, S ;
Paylor, R ;
Liyanage, M ;
Eckhaus, M ;
Collins, F ;
Shiloh, Y ;
Crawley, JN ;
Ried, T ;
Tagle, D ;
WynshawBoris, A .
CELL, 1996, 86 (01) :159-171
[3]   Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) or recombination-activating gene (RAG)1 activity [J].
Bemark, M ;
Sale, JE ;
Kim, HJ ;
Berek, C ;
Cosgrove, RA ;
Neuberger, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1509-1514
[4]   DISCRIMINATING INTRINSIC AND ANTIGEN-SELECTED MUTATIONAL HOTSPOTS IN IMMUNOGLOBULIN V-GENES [J].
BETZ, AG ;
NEUBERGER, MS ;
MILSTEIN, C .
IMMUNOLOGY TODAY, 1993, 14 (08) :405-411
[5]   Ku80 is required for immunoglobulin isotype switching [J].
Casellas, R ;
Nussenzweig, A ;
Wuerffel, R ;
Pelanda, R ;
Reichlin, A ;
Suh, H ;
Qin, XF ;
Besmer, E ;
Kenter, A ;
Rajewsky, K ;
Nussenzweig, MC .
EMBO JOURNAL, 1998, 17 (08) :2404-2411
[6]   Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation [J].
Ehrenstein, MR ;
Neuberger, MS .
EMBO JOURNAL, 1999, 18 (12) :3484-3490
[7]   Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination [J].
Ehrenstein, MR ;
Rada, C ;
Jones, AM ;
Milstein, C ;
Neuberger, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14553-14558
[8]   Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity [J].
Gately, DP ;
Hittle, JC ;
Chan, GKT ;
Yen, TJ .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (09) :2361-2374
[9]  
Gatti RA, 2001, METABOLIC MOL BASIS, P705
[10]   Histone H1 dephosphorylation is mediated through a radiation-induced signal transduction pathway dependent on ATM [J].
Guo, CY ;
Wang, Y ;
Brautigan, DL ;
Larner, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18715-18720